Literature DB >> 35199286

Role of nanoparticles in transarterial radioembolization with glass microspheres.

Asra Sadat Talebi1, Hossein Rajabi2, Hiroshi Watabe3.   

Abstract

OBJECTIVE: Transarterial Radioembolization (TARE) with 90Y-loaded glass microspheres is a locoregional treatment option for Hepatocellular Carcinoma (HCC). Post-treatment 90Y bremsstrahlung imaging using Single-Photon Emission Tomography (SPECT) is currently a gold-standard imaging modality for quantifying the delivered dose. However, the nature of bremsstrahlung photons causes difficulty for dose estimation using SPECT imaging. This work aimed to investigate the possibility of using glass microspheres loaded with 90Y and Nanoparticles (NPs) to improve the quantification of delivered doses.
METHODS: The Monte Carlo codes were used to simulate the post-TARE 90Y planar imaging. Planar images from bremsstrahlung photons and characteristic X-rays are acquired when 0, 1.2 mol/L, 2.4 mol/L, and 4.8 mol/L of Gold (Au), Hafnium (Hf), and Gadolinium (Gd) NPs are incorporated into the glass microspheres. We evaluated the quality of acquired images by calculating sensitivity and Signal-to-Background Ratio (SBR). Therapeutic effects of NPs were evaluated by calculation of Dose Enhancement Ratio (DER) in tumoral and non-tumoral liver tissues.
RESULTS: The in silico results showed that the sensitivity values of bremsstrahlung and characteristic X-ray planar images increased significantly as the NPs concentration increased in the glass microspheres. The SBR values decreased as the NPs concentration increased for the bremsstrahlung planar images. In contrast, the SBR values increased for the characteristic X-ray planar images when Hf and Gd were incorporated into the glass microspheres. The DER values decreased in the tumoral and non-tumoral liver tissues as the NPs concentration increased. The maximum dose reduction was observed at the NPs concentration of 4.8 mol/L (≈ 7%).
CONCLUSIONS: The incorporation of Au, Hf, and Gd NPs into the glass microspheres improved the quality and quantity of post-TARE planar images. Also, treatment efficiency was decreased significantly at NPs concentration > 4.8 mol/L.
© 2022. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.

Entities:  

Keywords:  Glass microsphere; Monte Carlo; Nanoparticles; Planar imaging; Transarterial radioembolization

Mesh:

Substances:

Year:  2022        PMID: 35199286     DOI: 10.1007/s12149-022-01727-7

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.258


  25 in total

1.  Development and evaluation of an improved quantitative (90)Y bremsstrahlung SPECT method.

Authors:  Xing Rong; Yong Du; Michael Ljungberg; Erwann Rault; Stefaan Vandenberghe; Eric C Frey
Journal:  Med Phys       Date:  2012-05       Impact factor: 4.071

2.  Analysis of the influence of 111In on 90Y-bremsstrahlung SPECT based on Monte Carlo simulation.

Authors:  Hiroaki Shiba; Akihiko Takahashi; Shingo Baba; Kazuhiko Himuro; Yasuo Yamashita; Masayuki Sasaki
Journal:  Ann Nucl Med       Date:  2016-08-10       Impact factor: 2.668

Review 3.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Robin Kate Kelley; Augusto Villanueva; Amit G Singal; Eli Pikarsky; Sasan Roayaie; Riccardo Lencioni; Kazuhiko Koike; Jessica Zucman-Rossi; Richard S Finn
Journal:  Nat Rev Dis Primers       Date:  2021-01-21       Impact factor: 52.329

4.  Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models.

Authors:  Justin K Mikell; Armeen Mahvash; Wendy Siman; Veera Baladandayuthapani; Firas Mourtada; S Cheenu Kappadath
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-27       Impact factor: 7.038

5.  Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.

Authors:  John D Gordan; Erin B Kennedy; Ghassan K Abou-Alfa; Muhammad Shaalan Beg; Steven T Brower; Terence P Gade; Laura Goff; Shilpi Gupta; Jennifer Guy; William P Harris; Renuka Iyer; Ishmael Jaiyesimi; Minaxi Jhawer; Asha Karippot; Ahmed O Kaseb; R Kate Kelley; Jennifer J Knox; Jeremy Kortmansky; Andrea Leaf; William M Remak; Rachna T Shroff; Davendra P S Sohal; Tamar H Taddei; Neeta K Venepalli; Andrea Wilson; Andrew X Zhu; Michal G Rose
Journal:  J Clin Oncol       Date:  2020-11-16       Impact factor: 44.544

6.  Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients.

Authors:  K Okuda; K Ohnishi; K Kimura; S Matsutani; M Sumida; N Goto; H Musha; M Takashi; N Suzuki; T Shinagawa
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

7.  Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.

Authors:  Bree R Eaton; Hyun S Kim; Eduard Schreibmann; David M Schuster; James R Galt; Bruce Barron; Sungjin Kim; Yuan Liu; Jerome Landry; Tim Fox
Journal:  J Vasc Interv Radiol       Date:  2013-10-23       Impact factor: 3.464

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

Review 9.  Epidemiology of Hepatocellular Carcinoma.

Authors:  Katherine A McGlynn; Jessica L Petrick; Hashem B El-Serag
Journal:  Hepatology       Date:  2020-11-24       Impact factor: 17.298

Review 10.  Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer.

Authors:  Rou Li; Danni Li; Guorong Jia; Xiao Li; Gaofeng Sun; Changjing Zuo
Journal:  Front Oncol       Date:  2021-01-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.